Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,123.00
-1.2100-0.11%
Post-market: 1,125.002.00+0.18%19:28 EDT
Volume:2.00M
Turnover:2.25B
Market Cap:1.06T
PE:37.70
High:1,133.79
Open:1,126.08
Low:1,120.52
Close:1,124.21
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.86
T/O Rate:0.21%
Dividend:6.69
Dividend Rate:0.60%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.34
PE(LYR):48.93

Loading ...

Scotiabank Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 06

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Dow Jones
·
Aug 06

Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley

TIPRANKS
·
Aug 06

Wells Fargo Adjusts PT on Eli Lilly and Co. to $1,330 From $1,280, Maintains Overweight Rating

MT Newswires Live
·
Aug 06

Eli Lilly Buy Rating Reaffirmed as Obesity Leadership Drives Outlook; Price Target Raised to $1,344 from $1,334

TIPRANKS
·
Aug 06

Street View: Lilly Remains the Front-Runner as GLP-1 Demand Climbs

Reuters
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Dow Hits New All-Time High: Investor Sentiment Improves, Fear Index In ‘Greed’ Zone

Benzinga Earnings
·
Aug 06

Eli Lilly (LLY) Stock Climbs On GLP 1 Strength And 86% Margin

Simply Wall St.
·
Aug 06

Eli Lilly : Leerink Partners Raises Target Price to $1,309.00 from $1,232.00

THOMSON REUTERS
·
Aug 06

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy

Dow Jones
·
Aug 06

Eli Lilly Earnings Call Highlights Powerful Growth Momentum

TIPRANKS
·
Aug 06

Global Equities Roundup: Market Talk

Dow Jones
·
Aug 06

Exchange Traded Funds Top 10 Percentage Gainers

Dow Jones
·
Aug 06

Eli Lilly & Co. Stock Advances 4.9%, Outperforms Peers

Dow Jones
·
Aug 06

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Dow Jones
·
Aug 06

SpaceX, Alphabet, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 06

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Dow Jones
·
Aug 06

Eli Lilly Doesn't Want to be Seen as 'Just an Obesity Company'

Dow Jones
·
Aug 06

Eli Lilly is Leading the Pharmaceutical Segment, CEO Says

Dow Jones
·
Aug 06